Scientists are leveraging ddPCR technology to get an accurate read on viral titer and vector copy number.
Marwan Alsarraj
Advertisement
Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.
Articles by Marwan Alsarraj
One get obtain a clearer assessment of gene-editing outcomes through more exacting analytical tools.
CAR-T cell therapy development is a complex process that requires standardization.
Advertisement
Latest Updated Articles
Assessing the Quality of CAR-T Cells Using ddPCRPublished: March 15th 2022 | Updated:
Navigating the Intricacies of Lentiviral CGTsPublished: September 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
